1-3 of 3
Renate Konopitzky
Close
Sort by
Journal Articles

Decitabine enhances anti-CD33 monoclonal antibody BI 836858–mediated natural killer ADCC against AML blasts

Sumithira Vasu, Shun He, Carolyn Cheney, Bhavani Gopalakrishnan, Rajeswaran Mani, Gerard Lozanski, Xiaokui Mo, Veronica Groh, Susan P. Whitman, Renate Konopitzky, Christian Kössl, Donna Bucci, David M. Lucas, Jianhua Yu, Michael A. Caligiuri, William Blum, Paul J. Adam, Eric Borges, Bjoern Rueter, Karl-Heinz Heider, Guido Marcucci, Natarajan Muthusamy
Journal: Blood
Blood (2016) 127 (23): 2879–2889.
https://doi.org/10.1182/blood-2015-11-680546
Published: 2016
Includes: Supplemental data
Journal Articles

A Novel Fc-Engineered Antibody to CD33 with Enhanced ADCC Activity for Treatment of AML

Karl-Heinz Heider, PhD, Renate Konopitzky, PhD, Elinborg Ostermann, PhD, Herbert Lamche, PhD, Zaruhi Kuepcue, PhD, Christian Koessl, Ph.D., Paul Adam, Ph.D., Eric Borges, PhD
Journal: Blood
Blood (2012) 120 (21): 1363.
https://doi.org/10.1182/blood.V120.21.1363.1363
Published: 2012
Journal Articles

Novel Fc-Engineered Antibodies to CD37 with Pro-Apoptotic and Enhanced ADCC Activity

Karl-Heinz Heider, PhD, Elinborg Ostermann, PhD, Herbert Lamche, PhD, Zaruhi Kuepcue, PhD, Alexander Jacobi, PhD, Renate Konopitzky, PhD, Ulrich Hirt, PhD, Volker Reichardt, MD, Eric Borges, PhD
Journal: Blood
Blood (2010) 116 (21): 3916.
https://doi.org/10.1182/blood.V116.21.3916.3916
Published: 2010